Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis

Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis

Resource Type

CF Research News

Authors

Cameron J McKinzie, Christina T Doligalski, Steven J Lobritto, Raymond D Coakley, W Adam Gower

References

J Cyst Fibros. 2021 Aug 9;S1569-1993(21)01336-9. doi: 10.1016/j.jcf.2021.07.017.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR modulator; Cystic fibrosis; Liver transplantation [3]

Date

Monday, August 9, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [4]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/use-elexacaftortezacaftorivacaftor-liver-transplant-patients

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00232R1_FINAL_McKinzie_220821.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34384711/ [3] https://www.ecfs.eu/research-article-keywords/cftr-modulator-cystic-fibrosis-liver-transplantation [4] https://www.ecfs.eu/resource-guideline-type/other-guidelines